Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by dataworkon Aug 07, 2020 9:50pm

131 Views

Post# 31381853

RE:RE:RE:RE:False positives

Thank you, Pandora

There is the answer I been looking for. I know Quidell has been issues with their test.
I'm happy to hear that the FDA has created a level playing field. It's unforunate that Sona has been caught in the cross over but I feel we will come through with flying colours. This needed to be done before Antigen testing gets a BAD rap for being UNRELIABLE.

Sona could very well be the last antigen test standing in 60 days. I know that one of the companies with antigen test EUA has some serious work ahhead of them in the next 60 days to be compliant.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features